Simpson Curran
SEC CIK 1346164 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGNX | REGENXBIO Inc. | Chief Oper, Tech. Off | 338.1K | — | $563.2K | 19 | 2022-01-01 | 2026-07-01 |
Most active insiders at RGNX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ciongoli Gregory Austin | Dir | $949.4K | — |
| 2 | PAKOLA STEVE | Chief Medical Off | — | $940.0K |
| 3 | Simpson Curran | CEO, Dir | — | $339.1K |
| 4 | Malzahn Craig | CTO | — | — |
| 5 | Bennett Jean | Dir | — | — |
| 6 | Chan Mitchell | CFO | — | — |
| 7 | Zachary Jennifer | Dir | — | — |
| 8 | Glucksmann Alexandra | Dir | — | — |
| 9 | Fox Allan M. | Dir | — | — |
| 10 | Mills Kenneth T. | Dir | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-07-06 16:51 | 2025-12-31+ | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | A - Grant | $8.92 | +2,404 | 344.9K | +0.7% | +$21.4K |
| 2026-07-06 16:51 | 2026-07-01 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | F - Tax | $13.09 | -6,818 | 338.1K | -2% | -$89.2K | |
| D | 2026-01-08 | 2026-01-06 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | A - Grant | $0.00 | +144.9K | 342.5K | +73% | $0 |
| 2026-01-06 | 2026-01-02 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | F - Tax | $14.40 | -18.6K | 197.6K | -9% | -$267.2K | |
| T | 2025-10-10 | 2025-10-09 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | S - Sale | $12.62 | -20.8K | 216.2K | -9% | -$262.6K |
| T | 2025-10-01 | 2025-09-29 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | S - Sale | $10.03 | -7,624 | 237.0K | -3% | -$76.5K |
| T | 2025-09-12 | 2025-09-10 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | S - Sale | $10.02 | -7,734 | 244.6K | -3% | -$77.5K |
| 2025-07-03 | 2025-07-01 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | F - Tax | $8.23 | -4,701 | 252.3K | -2% | -$38.7K | |
| D | 2025-01-06 | 2025-01-02 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | F - Tax | $7.73 | -11.9K | 158.1K | -7% | -$92.1K |
| D | 2025-01-06 | 2025-01-02 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | A - Grant | $0.00 | +98.9K | 257.0K | +63% | $0 |
| T | 2024-08-05 | 2024-08-01 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | S - Sale | $15.00 | -100 | 170.0K | -0.1% | -$1,500 |
| T | 2024-07-30 | 2024-07-29 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | S - Sale | $15.04 | -9,648 | 170.1K | -5% | -$145.1K |
| D | 2024-07-03 | 2024-07-01 | RGNX | REGENXBIO Inc. | Simpson Curran | CEO, Dir | A - Grant | $0.00 | +56.5K | 179.8K | +46% | $0 |
| D | 2024-01-04 | 2024-01-02 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper, Tech. Off | A - Grant | $0.00 | +38.5K | 123.3K | +45% | $0 |
| D | 2024-01-04 | 2024-01-02 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper, Tech. Off | F - Tax | $17.95 | -8,120 | 84.9K | -9% | -$145.8K |
| D | 2023-01-05 | 2023-01-03 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper, Tech. Off | F - Tax | $22.68 | -2,076 | 25.0K | -8% | -$47.1K |
| D | 2023-01-05 | 2023-01-03 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper, Tech. Off | A - Grant | $0.00 | +67.9K | 93.0K | +271% | $0 |
| D | 2022-01-04 | 2022-01-01 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper, Tech. Off | F - Tax | $32.70 | -1,332 | 16.4K | -8% | -$43.6K |
| D | 2022-01-04 | 2022-01-03 | RGNX | REGENXBIO Inc. | Simpson Curran | Chief Oper, Tech. Off | A - Grant | $0.00 | +10.7K | 27.1K | +65% | $0 |
Purchase Sale Sale after option exercise All abbreviations